Literature DB >> 12365930

Tamoxifen maculopathy.

Amar Alwitry1, Iain Gardner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12365930     DOI： 10.1001/archopht.120.10.1402

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  4 in total

1.  [Unusual symptoms for tamoxifen-associated maculopathy].

Authors:  T Hager; S Hoffmann; B Seitz
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

2.  Tamoxifen therapy conveys increased risk of developing a macular hole.

Authors:  Brendan G Cronin; Christopher K Lekich; Robert D Bourke
Journal:  Int Ophthalmol       Date:  2006-09-15       Impact factor: 2.031

3.  [Tamoxifen retinopathy: a case series of clinical and functional data].

Authors:  C Ritter; A B Renner; J Wachtlin; N E Bechrakis; L Krause
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

4.  The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors.

Authors:  Nicole Koulisis; Stavros N Moysidis; Lisa C Olmos de Koo; Christy A Russell; Amir H Kashani
Journal:  Am J Ophthalmol Case Rep       Date:  2016-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.